Results 1 to 10 of about 8,414 (207)

The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis [PDF]

Experimental Hematology & Oncology, 2022
Erythrocytosis is a clinical condition characterized by increased red cell mass, hemoglobin, and hematocrit values. A significant fraction of patients is described as having idiopathic erythrocytosis.
Antonella Zagaria, Francesco Tarantini, Paola Orsini, Luisa Anelli, Cosimo Cumbo, Nicoletta Coccaro, Giuseppina Tota, Crescenzio Francesco Minervini, Elisa Parciante, Maria Rosa Conserva, Immacolata Redavid, Alessandra Ricco, Immacolata Attolico, Giorgina Specchia, Pellegrino Musto, Francesco Albano   +15 more
doaj   +2 more sources

Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis

Saudi Journal of Kidney Diseases and Transplantation, 2014
Post-kidney transplant erythrocytosis (PTE) is one of the hematological complications in the renal transplant patients. While its pathogenesis still remains to be elucidated completely, a number of therapies are available for the management of PTE.
Chokri Maktouf, Soumaya Yaich, Sabra Aloui, Azza Bounemra, Khaled Charfeddine, Habib Skhiri, Jamil Hachicha   +6 more
doaj   +2 more sources

Congenital erythrocytosis [PDF]

European Journal of Haematology, 2021
AbstractErythrocytosis, or increased red cell mass, may be labeled as primary or secondary, depending on whether the molecular defect is intrinsic to the red blood cells/their precursors or extrinsic to them, the latter being typically associated with elevated erythropoietin (EPO) levels.
Nabhajit Mallik, Reena Das, Pankaj Malhotra, Prashant Sharma   +3 more
openaire   +2 more sources

Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis

Frontiers in Genetics, 2021
An erythrocytosis is present when the red blood cell mass is increased, demonstrated as elevated hemoglobin and hematocrit in the laboratory evaluation.
Aleša Kristan, Tadej Pajič, Tadej Pajič, Tadej Pajič, Aleš Maver, Tadeja Režen, Tanja Kunej, Rok Količ, Andrej Vuga, Martina Fink, Martina Fink, Špela Žula, Helena Podgornik, Helena Podgornik, Saša Anžej Doma, Saša Anžej Doma, Irena Preložnik Zupan, Irena Preložnik Zupan, Damjana Rozman, Nataša Debeljak   +19 more
doaj   +1 more source

Posttransplant erythrocytosis [PDF]

Kidney International, 2003
Posttransplant erythrocytosis (PTE) is defined as a persistently elevated hematocrit to a level greater than 51% after renal transplantation. It occurs in 10% to 15% of graft recipients and usually develops 8 to 24 months after engraftment. Spontaneous remission of established PTE is observed in one fourth of the patients within 2 years from onset ...
Vlahakos, Demetrios V., Marathias, Katerina P., Agroyannis, Basil, Madias, Nicolaos E.   +3 more
openaire   +2 more sources

Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study

BMJ Open Respiratory Research, 2021
Background Multidrug-resistant tuberculosis (MDR-TB) drugs have never been associated with erythrocytosis. In Eritrea, however, several cases of incident erythrocytosis had been observed in the MDR-TB hospital.
Henok Woldu, Sirak Tesfamariam, Mulugeta Russom, Amon Solomon Ghebrenegus, Ephrem Fisseha, Gebremeskel Belai   +5 more
doaj   +1 more source

First observation of hemoglobin ypsilanti in Saudi Arabia: A high oxygen affinity hemoglobin presenting with extreme erythrocytosis

Journal of Applied Hematology, 2023
High oxygen affinity hemoglobin (HOAH) variants are rare hemoglobinopathies sometimes associated with congenital erythrocytosis. Patients with HOAH are usually asymptomatic and are incidentally discovered when unexplained erythrocytosis is observed in ...
Husain Alkhaldy, Abdullah Algarni, Omayma Bakheet, Afaf Qahtani, Lama Alasiri, Mohammed Makkawi   +5 more
doaj   +1 more source

Congenital familial erythrocytosis: A case report with literature review

Saudi Journal of Medicine and Medical Sciences, 2015
Familial erythrocytosis is a heterogeneous group of hereditary conditions with an increased total red blood cell volume. The disease occurs in a familial pattern and follows a relatively benign course.
Ishrat H Dar, Showkat H Dar, Muqtasid A Kamili, Mohammad I Quadri, Hardeep S Wazir, Aijaz A Bhat   +5 more
doaj   +1 more source

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

Haematologica, 2019
Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk, Nigel S. Key, Josef T. Prchal   +2 more
doaj   +1 more source

Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study

Cardiovascular Diabetology, 2022
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have proven cardiovascular benefits in patients with type 2 diabetes (T2D). This self-controlled case series study aims to evaluate whether metformin use and SGLT2i-associated erythrocytosis ...
Carlos King Ho Wong, Kristy Tsz Kwan Lau, Eric Ho Man Tang, Chi Ho Lee, Carmen Yu Yan Lee, Yu Cho Woo, Ivan Chi Ho Au, Kathryn Choon Beng Tan, David Tak Wai Lui   +8 more
doaj   +1 more source